In some curable cancers like lymphomas, targeted therapy is added in addition to routine chemotherapy (called "immunotherapy") which definitely increases the chance of curability in these cancers at any stage.
It is important to distinguish the radiosensitivity of a particular tumor, which to some extent is a laboratory measure, from the radiation curability of a cancer in actual clinical practice.
